Results 21 to 30 of about 105,668 (383)

Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism

open access: yesToxins, 2021
Intradermal injection of botulinum neurotoxin is a frequently performed procedure in aesthetic dermatology to improve facial skin tone, texture, fine wrinkles, and enlarged pores.
Nark-Kyoung Rho, Y. Gil
semanticscholar   +1 more source

A summary index derived from Kinect to evaluate postural abnormalities severity in Parkinson’s Disease patients

open access: yesnpj Parkinson's Disease, 2022
Postural abnormalities are common disabling motor complications affecting patients with Parkinson’s disease (PD). We proposed a summary index for postural abnormalities (IPA) based on Kinect depth camera and explored the clinical value of this indicator.
Ronghua Hong   +13 more
doaj   +1 more source

Evaluation and Optimization of Microdrop Digital PCR for Detection of Serotype A and B Clostridium botulinum

open access: yesFrontiers in Microbiology, 2022
Clostridium botulinum is the causative pathogen of botulism. Laboratory detection of C. botulinum is essential for clinical therapy treatment of botulism due to the difficulty in diagnosis, especially in infant botulism. The extreme toxicity of botulinum
Pengya Gao   +10 more
doaj   +1 more source

Clostridial neurotoxins [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2004
The genus Clostridium comprises a number of spore forming Gram positive, rod shaped bacilli. They are found in the intestines of numerous mammalian species including domestic animals, horses, chickens, and humans. They are also widely distributed in the soil and in marine and freshwater sediments.
Goonetilleke A, Harris JB
openaire   +3 more sources

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease

open access: yesAntioxidants, 2020
Currently, neurodegenerative diseases are a major cause of disability around the world. Parkinson’s disease (PD) is the second-leading cause of neurodegenerative disorder after Alzheimer’s disease.
Maruthi Prasad E, Shih-Ya Hung
semanticscholar   +1 more source

The Distinctive Evolution of orfX Clostridium parabotulinum Strains and Their Botulinum Neurotoxin Type A and F Gene Clusters Is Influenced by Environmental Factors and Gene Interactions via Mobile Genetic Elements

open access: yesFrontiers in Microbiology, 2021
Of the seven currently known botulinum neurotoxin-producing species of Clostridium, C. parabotulinum, or C. botulinum Group I, is the species associated with the majority of human botulism cases worldwide.
Theresa J. Smith   +10 more
doaj   +1 more source

Loss of AP-3 function affects spontaneous and evoked release at hippocampal mossy fiber synapses [PDF]

open access: yes, 2006
Synaptic vesicle (SV) exocytosis mediating neurotransmitter release occurs spontaneously at low intraterminal calcium concentrations and is stimulated by a rise in intracellular calcium.
A. Scheuber   +32 more
core   +6 more sources

Release of vasopressin from isolated permeabilized neurosecretory nerve terminals is blocked by the light chain of botulinum A toxin [PDF]

open access: yes, 1990
The intracellular action on exocytosis of botulinim A toxin and constituent chains was studied using permeabilized isolated nerve endings from the rat neural lobe. The release of the neuropeptide vasopressin was measured by radioimmunoassay.
Ahnert-Hilger, G.   +4 more
core   +6 more sources

Evolution of Three-Finger Toxin Genes in Neotropical Colubrine Snakes (Colubridae)

open access: yesToxins, 2023
Snake venom research has historically focused on front-fanged species (Viperidae and Elapidae), limiting our knowledge of venom evolution in rear-fanged snakes across their ecologically diverse phylogeny.
Kristy Srodawa   +3 more
doaj   +1 more source

Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]

open access: yes, 2013
Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Dasgupta, P   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy